2020 annual financial data

Bolt Biotherapeutics, Inc. 2020 Operating margin

Bolt Biotherapeutics, Inc. 2020 operating margin with verified reported values.

Direct answer

Operating margin was -21,290.91%.

Operating income was -49,182,000 USD and net income was -60,728,000 USD.
Operating cash flow was -47,308,000 USD.

Get free Bolt Biotherapeutics, Inc. email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
231,000 USD
Operating income
-49,182,000 USD
Net income
-60,728,000 USD
Operating cash flow
-47,308,000 USD